Metropolitan Life Insurance Company (MetLife)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,246
| Closed | -$5.82K | – | 2462 |
|
|
2023
Q2 | $5.82K | Hold |
2,246
| – | – | ﹤0.01% | 2447 |
|
|
2023
Q1 | $9.16K | Sell |
2,246
-146
| -6% | -$596 | ﹤0.01% | 2191 |
|
|
2022
Q4 | $12K | Hold |
2,392
| – | – | ﹤0.01% | 2224 |
|
|
2022
Q3 | $31.3K | Hold |
2,392
| – | – | ﹤0.01% | 1777 |
|
|
2022
Q2 | $30.7K | Buy |
2,392
+663
| +38% | +$8.5K | ﹤0.01% | 1805 |
|
|
2022
Q1 | $26.4K | Sell |
1,729
-7,528
| -81% | -$115K | ﹤0.01% | 1960 |
|
|
2021
Q4 | $164K | Hold |
9,257
| – | – | ﹤0.01% | 2156 |
|
|
2021
Q3 | $195K | Hold |
9,257
| – | – | ﹤0.01% | 2089 |
|
|
2021
Q2 | $183K | Buy |
9,257
+1,110
| +14% | +$21.9K | ﹤0.01% | 2213 |
|
|
2021
Q1 | $237K | Sell |
8,147
-194
| -2% | -$5.64K | ﹤0.01% | 1900 |
|
|
2020
Q4 | $253K | Hold |
8,341
| – | – | ﹤0.01% | 1781 |
|
|
2020
Q3 | $133K | Hold |
8,341
| – | – | ﹤0.01% | 2053 |
|
|
2020
Q2 | $165K | Hold |
8,341
| – | – | ﹤0.01% | 1933 |
|
|
2020
Q1 | $103K | Hold |
8,341
| – | – | ﹤0.01% | 2011 |
|
|
2019
Q4 | $154K | Buy |
+8,341
| New | +$154K | ﹤0.01% | 2080 |
|